Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Arthritis, Rheumatoid × Exercise × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 107 Breast Neoplasms 64 Neoplasms 44 Prostatic Neoplasms 18 Obesity 14 Fatigue 13 Lung Neoplasms 11 Colorectal Neoplasms 11 Polycystic Ovary Syndrome 9 Colonic Neoplasms 8 Head and Neck Neoplasms 7 Weight Loss 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Ovarian Neoplasms 6 Rectal Neoplasms 5 Inflammation 5 Overweight 4 Multiple Myeloma 4 Lymphedema 4 Leukemia, Myeloid, Acute 4 Leukemia 4 Cognitive Dysfunction 4 Brain Neoplasms 4 Multiple Endocrine Neoplasia Type 1 3 Lymphoma, Follicular 3 Lymphoma 3 Insulin Resistance 3 Depression 3 Cardiotoxicity 3 Carcinoma, Non-Small-Cell Lung 3

Interventions

Adalimumab 10 Etanercept 8 Methotrexate 6 tocilizumab 5 golimumab 5 Rituximab 5 Abatacept 5 tofacitinib 4 Certolizumab Pegol 4 olokizumab 3 Infliximab 3 Tumor Necrosis Factor Inhibitors 2 Saline Solution 2 Antirheumatic Agents 2 upadacitinib 1 secukinumab 1 sarilumab 1 mavrilimumab 1 baricitinib 1 Vitamin D 1 Vaccines 1 Syringes 1 Sulfasalazine 1 Radioimmunodetection 1 RC-18 1 Pharmaceutical Preparations 1 Lysine Acetyltransferase 5 1 Leflunomide 1 ISIS104838 1 Hydroxychloroquine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05215509 2024-02-02

RABEX

Rigshospitalet, Denmark

Phase NA Completed

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡